- Home
- KMB vs ALC Comparison
KMB vs ALC Comparison
Compare KMB & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMB
- ALC
- Stock Information
- Founded
- KMB 1910
- ALC 1945
- Country
- KMB United States
- ALC Switzerland
- Employees
- KMB N/A
- ALC N/A
- Industry
- KMB Containers/Packaging
- ALC Ophthalmic Goods
- Sector
- KMB Consumer Discretionary
- ALC Health Care
- Exchange
- KMB Nasdaq
- ALC Nasdaq
- Market Cap
- KMB 44.1B
- ALC 41.0B
- IPO Year
- KMB N/A
- ALC N/A
- Fundamental
- Price
- KMB $127.21
- ALC $84.37
- Analyst Decision
- KMB Hold
- ALC Strong Buy
- Analyst Count
- KMB 14
- ALC 14
- Target Price
- KMB $143.71
- ALC $102.53
- AVG Volume (30 Days)
- KMB 2.0M
- ALC 801.5K
- Earning Date
- KMB 01-28-2025
- ALC 02-25-2025
- Dividend Yield
- KMB 3.84%
- ALC 0.31%
- EPS Growth
- KMB 48.45
- ALC 156.61
- EPS
- KMB 7.72
- ALC 2.34
- Revenue
- KMB $20,100,000,000.00
- ALC $9,761,000,000.00
- Revenue This Year
- KMB N/A
- ALC $5.43
- Revenue Next Year
- KMB N/A
- ALC $6.42
- P/E Ratio
- KMB $16.48
- ALC $35.98
- Revenue Growth
- KMB N/A
- ALC 5.25
- 52 Week Low
- KMB $117.67
- ALC $74.30
- 52 Week High
- KMB $149.31
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- KMB 40.89
- ALC 46.68
- Support Level
- KMB $125.02
- ALC $82.31
- Resistance Level
- KMB $127.23
- ALC $83.68
- Average True Range (ATR)
- KMB 1.78
- ALC 1.04
- MACD
- KMB -0.03
- ALC 0.14
- Stochastic Oscillator
- KMB 33.44
- ALC 59.71
About KMB Kimberly-Clark Corporation
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.